Kolber, W.; Kuśnierz-Cabala, B.; Dumnicka, P.; Maraj, M.; Mazur-Laskowska, M.; Pędziwiatr, M.; Ceranowicz, P.
Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis. J. Clin. Med. 2018, 7, 305.
https://doi.org/10.3390/jcm7100305
AMA Style
Kolber W, Kuśnierz-Cabala B, Dumnicka P, Maraj M, Mazur-Laskowska M, Pędziwiatr M, Ceranowicz P.
Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis. Journal of Clinical Medicine. 2018; 7(10):305.
https://doi.org/10.3390/jcm7100305
Chicago/Turabian Style
Kolber, Witold, Beata Kuśnierz-Cabala, Paulina Dumnicka, Małgorzata Maraj, Małgorzata Mazur-Laskowska, Michał Pędziwiatr, and Piotr Ceranowicz.
2018. "Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis" Journal of Clinical Medicine 7, no. 10: 305.
https://doi.org/10.3390/jcm7100305
APA Style
Kolber, W., Kuśnierz-Cabala, B., Dumnicka, P., Maraj, M., Mazur-Laskowska, M., Pędziwiatr, M., & Ceranowicz, P.
(2018). Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis. Journal of Clinical Medicine, 7(10), 305.
https://doi.org/10.3390/jcm7100305